CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

SIMONE BERTINI

ORCID: 0000-0001-8832-8075↗

Public evidence

5 connected articles

Recent Progress in the Development of Selective MAGL Modulators (2020-2026).2026 · PubMed Central Open Access Methods for Assessing MAGL Enzymatic Activity: An Extensive Review of Past and Emerging Approaches.2025 · Europe PMC Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1<i>H</i>)-One Scaffold.2022 · Europe PMC Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist.2020 · Europe PMC Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis.2018 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

SIMONE BERTINI - Medical Cannabis Research Engine